Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Vesico-Ureteral Reflux | 42 | 2024 | 437 | 12.010 |
Why?
|
Urology | 26 | 2024 | 423 | 6.750 |
Why?
|
Urinary Tract Infections | 22 | 2022 | 812 | 5.830 |
Why?
|
Urolithiasis | 12 | 2023 | 132 | 4.490 |
Why?
|
Bladder Exstrophy | 12 | 2023 | 106 | 3.960 |
Why?
|
Urologic Surgical Procedures | 23 | 2021 | 309 | 3.660 |
Why?
|
Hydronephrosis | 9 | 2023 | 271 | 3.590 |
Why?
|
Ureter | 13 | 2023 | 375 | 3.350 |
Why?
|
Ureteroscopy | 13 | 2024 | 148 | 2.980 |
Why?
|
Kidney Calculi | 10 | 2024 | 468 | 2.950 |
Why?
|
Circumcision, Male | 9 | 2023 | 148 | 2.790 |
Why?
|
Kidney Pelvis | 13 | 2018 | 188 | 2.640 |
Why?
|
Urinary Bladder | 11 | 2023 | 1166 | 2.620 |
Why?
|
Ureteral Obstruction | 11 | 2018 | 292 | 2.060 |
Why?
|
Urinary Tract | 4 | 2023 | 309 | 1.970 |
Why?
|
Hypospadias | 9 | 2023 | 98 | 1.910 |
Why?
|
Replantation | 6 | 2017 | 145 | 1.630 |
Why?
|
Spermatic Cord Torsion | 3 | 2020 | 73 | 1.600 |
Why?
|
Urologic Diseases | 6 | 2024 | 248 | 1.590 |
Why?
|
Urography | 5 | 2016 | 312 | 1.580 |
Why?
|
Spinal Dysraphism | 3 | 2023 | 174 | 1.500 |
Why?
|
Cryptorchidism | 5 | 2023 | 151 | 1.480 |
Why?
|
Child | 109 | 2024 | 79813 | 1.350 |
Why?
|
Infant | 71 | 2024 | 36054 | 1.340 |
Why?
|
Lithotripsy | 6 | 2024 | 141 | 1.300 |
Why?
|
Pediatrics | 11 | 2024 | 3587 | 1.260 |
Why?
|
Urination | 4 | 2024 | 202 | 1.260 |
Why?
|
Antibiotic Prophylaxis | 7 | 2023 | 642 | 1.250 |
Why?
|
Cystinuria | 2 | 2020 | 19 | 1.250 |
Why?
|
Child, Preschool | 72 | 2024 | 42058 | 1.230 |
Why?
|
Urethra | 5 | 2016 | 406 | 1.140 |
Why?
|
Urologic Surgical Procedures, Male | 4 | 2017 | 80 | 1.120 |
Why?
|
Fluoroscopy | 7 | 2021 | 944 | 1.090 |
Why?
|
Urethral Stricture | 2 | 2017 | 51 | 1.020 |
Why?
|
Urogenital Abnormalities | 4 | 2017 | 256 | 0.990 |
Why?
|
Dilatation, Pathologic | 4 | 2023 | 527 | 0.980 |
Why?
|
Hospitals, Pediatric | 12 | 2021 | 1854 | 0.960 |
Why?
|
Enuresis | 1 | 2024 | 50 | 0.940 |
Why?
|
Phimosis | 2 | 2023 | 10 | 0.920 |
Why?
|
Ureteral Calculi | 3 | 2024 | 116 | 0.910 |
Why?
|
Health Services Research | 3 | 2016 | 1812 | 0.890 |
Why?
|
Urinary Incontinence | 4 | 2020 | 495 | 0.890 |
Why?
|
Clinical Alarms | 1 | 2024 | 61 | 0.870 |
Why?
|
Editorial Policies | 4 | 2020 | 456 | 0.850 |
Why?
|
Ultrasonography, Prenatal | 4 | 2019 | 1745 | 0.810 |
Why?
|
Diagnostic Techniques, Urological | 2 | 2012 | 28 | 0.810 |
Why?
|
Male | 134 | 2024 | 358742 | 0.810 |
Why?
|
Humans | 192 | 2024 | 758381 | 0.790 |
Why?
|
Orchiectomy | 2 | 2021 | 470 | 0.780 |
Why?
|
Cerebral Palsy | 2 | 2023 | 472 | 0.770 |
Why?
|
Genital Diseases, Female | 1 | 2023 | 191 | 0.770 |
Why?
|
Kidney | 9 | 2021 | 7016 | 0.740 |
Why?
|
Gastrostomy | 2 | 2014 | 321 | 0.730 |
Why?
|
Radionuclide Imaging | 3 | 2021 | 1975 | 0.720 |
Why?
|
Urodynamics | 6 | 2024 | 346 | 0.700 |
Why?
|
Urinary Diversion | 2 | 2015 | 135 | 0.690 |
Why?
|
Intermittent Urethral Catheterization | 1 | 2019 | 14 | 0.670 |
Why?
|
Kidney Diseases | 2 | 2021 | 2083 | 0.650 |
Why?
|
Publishing | 3 | 2020 | 833 | 0.640 |
Why?
|
Evidence-Based Medicine | 3 | 2017 | 3671 | 0.630 |
Why?
|
Medical Records | 2 | 2014 | 1406 | 0.620 |
Why?
|
Retrospective Studies | 51 | 2023 | 80170 | 0.610 |
Why?
|
Female | 103 | 2024 | 390316 | 0.600 |
Why?
|
Telemedicine | 7 | 2024 | 3018 | 0.600 |
Why?
|
Urinary Bladder, Neurogenic | 3 | 2017 | 174 | 0.590 |
Why?
|
Feasibility Studies | 7 | 2024 | 5199 | 0.590 |
Why?
|
Enteral Nutrition | 2 | 2014 | 785 | 0.580 |
Why?
|
Adolescent | 52 | 2024 | 87888 | 0.570 |
Why?
|
Cicatrix | 3 | 2020 | 781 | 0.560 |
Why?
|
Epispadias | 3 | 2013 | 19 | 0.560 |
Why?
|
Internet | 5 | 2016 | 3082 | 0.560 |
Why?
|
Ultrasonography, Doppler | 1 | 2019 | 463 | 0.560 |
Why?
|
Nephrolithiasis | 4 | 2022 | 114 | 0.540 |
Why?
|
Recurrence | 10 | 2021 | 8426 | 0.540 |
Why?
|
Dextrans | 2 | 2009 | 573 | 0.540 |
Why?
|
Laparoscopy | 7 | 2018 | 2147 | 0.540 |
Why?
|
Penis | 6 | 2023 | 213 | 0.530 |
Why?
|
Prenatal Diagnosis | 4 | 2019 | 1264 | 0.530 |
Why?
|
Diurnal Enuresis | 1 | 2015 | 3 | 0.510 |
Why?
|
Reading | 1 | 2019 | 529 | 0.510 |
Why?
|
Cystostomy | 1 | 2015 | 25 | 0.500 |
Why?
|
Testicular Neoplasms | 1 | 2021 | 801 | 0.500 |
Why?
|
Nephrectomy | 4 | 2013 | 1016 | 0.500 |
Why?
|
Acetaminophen | 1 | 2019 | 552 | 0.500 |
Why?
|
Infant, Newborn | 24 | 2020 | 26182 | 0.490 |
Why?
|
Mass Screening | 5 | 2020 | 5425 | 0.490 |
Why?
|
Hyaluronic Acid | 2 | 2009 | 482 | 0.490 |
Why?
|
Radiation Injuries | 2 | 2013 | 1182 | 0.490 |
Why?
|
Periodicals as Topic | 3 | 2020 | 1462 | 0.480 |
Why?
|
Diabetes Complications | 2 | 2012 | 1317 | 0.480 |
Why?
|
Postoperative Complications | 12 | 2022 | 15638 | 0.470 |
Why?
|
Appendix | 1 | 2015 | 110 | 0.460 |
Why?
|
Specialties, Surgical | 1 | 2019 | 388 | 0.460 |
Why?
|
Postoperative Care | 3 | 2020 | 1471 | 0.460 |
Why?
|
Costs and Cost Analysis | 8 | 2020 | 1673 | 0.460 |
Why?
|
Ureteroscopes | 2 | 2011 | 22 | 0.450 |
Why?
|
Ultrasonography | 13 | 2021 | 5952 | 0.450 |
Why?
|
Animal Experimentation | 2 | 2023 | 46 | 0.450 |
Why?
|
Siblings | 2 | 2015 | 824 | 0.450 |
Why?
|
Reperfusion Injury | 1 | 2020 | 1022 | 0.440 |
Why?
|
Rural Health Services | 1 | 2017 | 381 | 0.440 |
Why?
|
Urinary Fistula | 1 | 2013 | 43 | 0.430 |
Why?
|
Nursing Research | 2 | 2024 | 80 | 0.430 |
Why?
|
Social Participation | 1 | 2015 | 182 | 0.430 |
Why?
|
Orchiopexy | 4 | 2023 | 20 | 0.430 |
Why?
|
Cost-Benefit Analysis | 8 | 2016 | 5484 | 0.410 |
Why?
|
Artificial Intelligence | 2 | 2023 | 2551 | 0.400 |
Why?
|
Medical Informatics Applications | 1 | 2014 | 178 | 0.400 |
Why?
|
Sperm Injections, Intracytoplasmic | 1 | 2013 | 156 | 0.400 |
Why?
|
Information Dissemination | 2 | 2011 | 1128 | 0.400 |
Why?
|
Quality Improvement | 6 | 2024 | 3806 | 0.390 |
Why?
|
Testis | 3 | 2020 | 794 | 0.380 |
Why?
|
Societies, Medical | 3 | 2020 | 3891 | 0.370 |
Why?
|
Radiation Dosage | 5 | 2021 | 1956 | 0.370 |
Why?
|
Prune Belly Syndrome | 1 | 2010 | 4 | 0.360 |
Why?
|
Diagnostic Imaging | 3 | 2015 | 3526 | 0.360 |
Why?
|
Atlases as Topic | 1 | 2011 | 241 | 0.350 |
Why?
|
Markov Chains | 2 | 2010 | 965 | 0.350 |
Why?
|
Quality of Life | 6 | 2023 | 13286 | 0.340 |
Why?
|
Ketorolac | 1 | 2010 | 94 | 0.330 |
Why?
|
Health Facility Size | 2 | 2007 | 62 | 0.330 |
Why?
|
Health Resources | 2 | 2013 | 931 | 0.330 |
Why?
|
Incidence | 12 | 2019 | 21273 | 0.320 |
Why?
|
Drug Resistance, Bacterial | 1 | 2016 | 1055 | 0.310 |
Why?
|
Patient Satisfaction | 3 | 2012 | 3446 | 0.310 |
Why?
|
Photography | 1 | 2011 | 530 | 0.310 |
Why?
|
Cost of Illness | 2 | 2015 | 1936 | 0.310 |
Why?
|
Observer Variation | 3 | 2019 | 2600 | 0.300 |
Why?
|
Prostate | 5 | 2003 | 1791 | 0.300 |
Why?
|
Occupational Exposure | 1 | 2018 | 1809 | 0.300 |
Why?
|
United States | 26 | 2024 | 72140 | 0.300 |
Why?
|
Documentation | 1 | 2014 | 892 | 0.290 |
Why?
|
Follow-Up Studies | 14 | 2021 | 39060 | 0.290 |
Why?
|
Reproducibility of Results | 9 | 2023 | 20052 | 0.280 |
Why?
|
Colon | 1 | 2015 | 1788 | 0.280 |
Why?
|
Fetal Diseases | 1 | 2012 | 911 | 0.280 |
Why?
|
Self Report | 2 | 2019 | 3712 | 0.280 |
Why?
|
Ambulatory Surgical Procedures | 1 | 2011 | 465 | 0.270 |
Why?
|
Ambulatory Care Facilities | 5 | 2022 | 927 | 0.270 |
Why?
|
Obesity | 3 | 2015 | 12870 | 0.270 |
Why?
|
Prostatectomy | 4 | 2003 | 1956 | 0.260 |
Why?
|
Pediatric Nursing | 2 | 2024 | 104 | 0.260 |
Why?
|
Nephrocalcinosis | 2 | 2017 | 52 | 0.260 |
Why?
|
Technetium Tc 99m Dimercaptosuccinic Acid | 3 | 2021 | 81 | 0.260 |
Why?
|
Penile Diseases | 1 | 2005 | 45 | 0.250 |
Why?
|
Urinary Bladder Neck Obstruction | 1 | 2005 | 81 | 0.250 |
Why?
|
Endoscopy | 3 | 2017 | 1834 | 0.250 |
Why?
|
Guidelines as Topic | 1 | 2011 | 1386 | 0.240 |
Why?
|
Coitus | 1 | 2005 | 132 | 0.240 |
Why?
|
Kidney Neoplasms | 3 | 2011 | 4312 | 0.240 |
Why?
|
Health Status | 2 | 2015 | 4069 | 0.240 |
Why?
|
Glutathione Transferase | 3 | 2001 | 564 | 0.240 |
Why?
|
Health Education | 1 | 2011 | 1049 | 0.240 |
Why?
|
Fertilization in Vitro | 1 | 2013 | 1292 | 0.240 |
Why?
|
Fever | 4 | 2021 | 1617 | 0.230 |
Why?
|
Osteotomy | 2 | 2007 | 836 | 0.230 |
Why?
|
Decision Support Techniques | 3 | 2011 | 1996 | 0.230 |
Why?
|
Pelvic Bones | 1 | 2006 | 270 | 0.230 |
Why?
|
Genital Diseases, Male | 1 | 2004 | 83 | 0.230 |
Why?
|
Cystitis, Interstitial | 1 | 2004 | 66 | 0.230 |
Why?
|
Age Factors | 9 | 2019 | 18357 | 0.230 |
Why?
|
Severity of Illness Index | 5 | 2018 | 15785 | 0.220 |
Why?
|
Scrotum | 1 | 2004 | 116 | 0.220 |
Why?
|
Hospital Costs | 1 | 2010 | 960 | 0.220 |
Why?
|
Disorders of Sex Development | 1 | 2004 | 128 | 0.220 |
Why?
|
Time Factors | 12 | 2020 | 39873 | 0.220 |
Why?
|
Secondary Prevention | 3 | 2021 | 1475 | 0.220 |
Why?
|
Robotics | 4 | 2013 | 874 | 0.210 |
Why?
|
Pregnancy | 7 | 2023 | 29742 | 0.210 |
Why?
|
Young Adult | 15 | 2021 | 58808 | 0.210 |
Why?
|
Mouth Mucosa | 1 | 2005 | 426 | 0.210 |
Why?
|
Pilot Projects | 4 | 2024 | 8554 | 0.210 |
Why?
|
Lithotripsy, Laser | 1 | 2022 | 44 | 0.200 |
Why?
|
Pandemics | 3 | 2022 | 8611 | 0.200 |
Why?
|
Remission, Spontaneous | 3 | 2012 | 384 | 0.200 |
Why?
|
Dilatation | 1 | 2023 | 307 | 0.200 |
Why?
|
Treatment Outcome | 17 | 2023 | 64379 | 0.200 |
Why?
|
Peer Review, Research | 2 | 2022 | 340 | 0.200 |
Why?
|
Oxalates | 1 | 2022 | 98 | 0.200 |
Why?
|
Sufentanil | 1 | 2001 | 42 | 0.190 |
Why?
|
Cross-Sectional Studies | 9 | 2024 | 25953 | 0.190 |
Why?
|
Receptors, Purinergic P2 | 1 | 2022 | 150 | 0.190 |
Why?
|
Hypertension | 2 | 2012 | 8503 | 0.190 |
Why?
|
Reflex | 1 | 2003 | 376 | 0.190 |
Why?
|
Family | 1 | 2012 | 3188 | 0.190 |
Why?
|
Radiography | 4 | 2015 | 6955 | 0.190 |
Why?
|
Decision Making | 1 | 2015 | 3915 | 0.190 |
Why?
|
Angiomyolipoma | 1 | 2002 | 184 | 0.190 |
Why?
|
Abdominal Pain | 1 | 2007 | 1063 | 0.190 |
Why?
|
Nocturnal Enuresis | 1 | 2020 | 12 | 0.180 |
Why?
|
Equipment Design | 2 | 2024 | 3507 | 0.180 |
Why?
|
Biocompatible Materials | 1 | 2009 | 1688 | 0.180 |
Why?
|
Cohort Studies | 11 | 2022 | 41252 | 0.180 |
Why?
|
Multivariate Analysis | 6 | 2015 | 12096 | 0.180 |
Why?
|
beta Carotene | 1 | 2022 | 523 | 0.180 |
Why?
|
Risk Assessment | 4 | 2019 | 23883 | 0.180 |
Why?
|
Reoperation | 6 | 2015 | 4282 | 0.180 |
Why?
|
Length of Stay | 3 | 2010 | 6439 | 0.180 |
Why?
|
DNA Adducts | 1 | 2001 | 94 | 0.180 |
Why?
|
Tomography, X-Ray Computed | 5 | 2017 | 20500 | 0.180 |
Why?
|
Isoenzymes | 3 | 2001 | 1686 | 0.180 |
Why?
|
Minority Groups | 1 | 2007 | 1206 | 0.170 |
Why?
|
Lasers, Solid-State | 1 | 2022 | 175 | 0.170 |
Why?
|
Hospital Charges | 3 | 2007 | 357 | 0.170 |
Why?
|
Anti-Inflammatory Agents, Non-Steroidal | 1 | 2010 | 2270 | 0.170 |
Why?
|
Probability | 2 | 2019 | 2467 | 0.170 |
Why?
|
Infant, Premature, Diseases | 1 | 2005 | 708 | 0.170 |
Why?
|
Patient Education as Topic | 1 | 2009 | 2307 | 0.160 |
Why?
|
Calcium, Dietary | 1 | 2022 | 529 | 0.160 |
Why?
|
Equipment and Supplies | 1 | 2001 | 273 | 0.160 |
Why?
|
Anti-Bacterial Agents | 6 | 2022 | 7403 | 0.160 |
Why?
|
Delivery of Health Care | 1 | 2017 | 5331 | 0.160 |
Why?
|
Prospective Studies | 11 | 2024 | 54136 | 0.160 |
Why?
|
Urinary Bladder, Overactive | 1 | 2020 | 114 | 0.160 |
Why?
|
Risk Factors | 10 | 2022 | 73806 | 0.160 |
Why?
|
Hospitals | 4 | 2023 | 3888 | 0.160 |
Why?
|
Stents | 1 | 2010 | 3162 | 0.160 |
Why?
|
Urinary Bladder Neoplasms | 1 | 2011 | 2276 | 0.160 |
Why?
|
Hydromorphone | 1 | 2019 | 70 | 0.160 |
Why?
|
Carcinogens | 1 | 2001 | 451 | 0.160 |
Why?
|
Analgesia, Patient-Controlled | 1 | 2019 | 116 | 0.160 |
Why?
|
Parents | 2 | 2011 | 3548 | 0.150 |
Why?
|
Anesthesia, Spinal | 1 | 2001 | 280 | 0.150 |
Why?
|
Case-Control Studies | 4 | 2022 | 22031 | 0.150 |
Why?
|
Lidocaine | 1 | 2001 | 537 | 0.150 |
Why?
|
Administration, Topical | 1 | 2020 | 697 | 0.150 |
Why?
|
Potassium | 1 | 2022 | 1310 | 0.150 |
Why?
|
Peer Review | 1 | 2020 | 217 | 0.150 |
Why?
|
Cystoscopy | 2 | 2011 | 133 | 0.150 |
Why?
|
Lymphedema | 1 | 2004 | 524 | 0.150 |
Why?
|
Body Mass Index | 1 | 2015 | 12876 | 0.140 |
Why?
|
Nurse Practitioners | 1 | 2020 | 268 | 0.140 |
Why?
|
Image Processing, Computer-Assisted | 1 | 2014 | 8946 | 0.140 |
Why?
|
Double-Blind Method | 4 | 2019 | 12262 | 0.140 |
Why?
|
Pregnancy Trimester, Third | 1 | 2019 | 582 | 0.140 |
Why?
|
Prevalence | 2 | 2024 | 15646 | 0.140 |
Why?
|
Postnatal Care | 1 | 2019 | 260 | 0.140 |
Why?
|
Delayed Diagnosis | 1 | 2021 | 463 | 0.140 |
Why?
|
Predictive Value of Tests | 5 | 2020 | 15225 | 0.140 |
Why?
|
Monitoring, Intraoperative | 1 | 2003 | 939 | 0.140 |
Why?
|
Surgical Flaps | 1 | 2005 | 1669 | 0.140 |
Why?
|
Electronic Health Records | 1 | 2014 | 4761 | 0.140 |
Why?
|
Injections, Intraperitoneal | 1 | 2017 | 412 | 0.130 |
Why?
|
Atrophy | 2 | 2020 | 1627 | 0.130 |
Why?
|
Intraoperative Period | 1 | 2017 | 512 | 0.130 |
Why?
|
Radiopharmaceuticals | 3 | 2021 | 2634 | 0.130 |
Why?
|
Healthcare Disparities | 1 | 2011 | 3362 | 0.130 |
Why?
|
Prostate-Specific Antigen | 2 | 2003 | 2528 | 0.130 |
Why?
|
Anesthetics | 1 | 2001 | 522 | 0.130 |
Why?
|
Anion Transport Proteins | 1 | 2016 | 141 | 0.130 |
Why?
|
Disease Management | 2 | 2016 | 2500 | 0.130 |
Why?
|
Early Diagnosis | 3 | 2010 | 1177 | 0.120 |
Why?
|
Drug Industry | 1 | 2001 | 787 | 0.120 |
Why?
|
Congresses as Topic | 1 | 2020 | 799 | 0.120 |
Why?
|
Steroids | 1 | 2020 | 926 | 0.120 |
Why?
|
Urinary Incontinence, Urge | 1 | 2015 | 50 | 0.120 |
Why?
|
Imidazoles | 1 | 2001 | 1179 | 0.120 |
Why?
|
Pyelonephritis | 2 | 2012 | 75 | 0.120 |
Why?
|
Morphine | 1 | 2019 | 653 | 0.120 |
Why?
|
Anti-Infective Agents, Urinary | 1 | 2014 | 28 | 0.120 |
Why?
|
Massachusetts | 3 | 2020 | 8823 | 0.120 |
Why?
|
Perception | 1 | 2021 | 1196 | 0.120 |
Why?
|
Sex Characteristics | 1 | 2004 | 2621 | 0.110 |
Why?
|
Conflict of Interest | 1 | 2019 | 548 | 0.110 |
Why?
|
Prostatic Neoplasms | 5 | 2003 | 11336 | 0.110 |
Why?
|
Proportional Hazards Models | 3 | 2019 | 12440 | 0.110 |
Why?
|
Abdominal Injuries | 1 | 2016 | 359 | 0.110 |
Why?
|
Diagnostic Errors | 1 | 2021 | 1263 | 0.110 |
Why?
|
Urinary Incontinence, Stress | 1 | 2015 | 181 | 0.110 |
Why?
|
Odds Ratio | 2 | 2015 | 9650 | 0.110 |
Why?
|
Clinical Protocols | 2 | 2017 | 1436 | 0.110 |
Why?
|
Adenocarcinoma | 4 | 2003 | 6313 | 0.110 |
Why?
|
Databases, Factual | 4 | 2016 | 7980 | 0.100 |
Why?
|
Weight Loss | 1 | 2004 | 2671 | 0.100 |
Why?
|
Adult | 21 | 2020 | 219916 | 0.100 |
Why?
|
Sex Factors | 2 | 2019 | 10505 | 0.100 |
Why?
|
Practice Guidelines as Topic | 3 | 2019 | 7377 | 0.100 |
Why?
|
Treatment Failure | 3 | 2007 | 2640 | 0.100 |
Why?
|
Factor Analysis, Statistical | 1 | 2015 | 999 | 0.100 |
Why?
|
Poisson Distribution | 1 | 2013 | 505 | 0.100 |
Why?
|
Models, Statistical | 2 | 2021 | 5070 | 0.100 |
Why?
|
Hemostasis, Surgical | 1 | 2012 | 127 | 0.100 |
Why?
|
Electrocoagulation | 1 | 2012 | 152 | 0.100 |
Why?
|
Patient Preference | 2 | 2016 | 921 | 0.100 |
Why?
|
Comorbidity | 2 | 2020 | 10495 | 0.100 |
Why?
|
Disease-Free Survival | 3 | 2012 | 6821 | 0.100 |
Why?
|
Ischemia | 1 | 2020 | 1863 | 0.100 |
Why?
|
Specialization | 1 | 2016 | 776 | 0.100 |
Why?
|
Anastomosis, Surgical | 1 | 2015 | 983 | 0.100 |
Why?
|
Hospitals, Teaching | 2 | 2007 | 1159 | 0.090 |
Why?
|
Fructose | 1 | 2013 | 287 | 0.090 |
Why?
|
Dose-Response Relationship, Radiation | 1 | 2013 | 881 | 0.090 |
Why?
|
Accidents, Traffic | 1 | 2016 | 814 | 0.090 |
Why?
|
Adrenal Cortex Hormones | 1 | 2020 | 1870 | 0.090 |
Why?
|
Publications | 1 | 2013 | 194 | 0.090 |
Why?
|
Hospitalization | 2 | 2007 | 10653 | 0.090 |
Why?
|
Glucocorticoids | 1 | 2020 | 2144 | 0.090 |
Why?
|
Wounds, Nonpenetrating | 1 | 2016 | 793 | 0.090 |
Why?
|
Nephrons | 1 | 2011 | 168 | 0.090 |
Why?
|
Postoperative Period | 2 | 2006 | 1812 | 0.090 |
Why?
|
Consensus | 1 | 2019 | 3099 | 0.080 |
Why?
|
Morbidity | 1 | 2015 | 1754 | 0.080 |
Why?
|
Injections | 2 | 2010 | 830 | 0.080 |
Why?
|
Surgical Wound Infection | 2 | 2011 | 1526 | 0.080 |
Why?
|
Duodenum | 1 | 2012 | 485 | 0.080 |
Why?
|
Disease Progression | 3 | 2023 | 13468 | 0.080 |
Why?
|
Diagnosis, Differential | 3 | 2016 | 12951 | 0.080 |
Why?
|
Decision Trees | 1 | 2010 | 504 | 0.080 |
Why?
|
Pyridines | 1 | 2001 | 2860 | 0.080 |
Why?
|
Combined Modality Therapy | 1 | 2021 | 8530 | 0.080 |
Why?
|
Calcium | 1 | 2022 | 5721 | 0.080 |
Why?
|
Patient Selection | 1 | 2020 | 4244 | 0.080 |
Why?
|
Information Storage and Retrieval | 1 | 2014 | 820 | 0.080 |
Why?
|
Boston | 2 | 2019 | 9304 | 0.080 |
Why?
|
Age Distribution | 2 | 2016 | 2882 | 0.080 |
Why?
|
Computer Simulation | 1 | 2021 | 6201 | 0.070 |
Why?
|
Nomograms | 1 | 2009 | 237 | 0.070 |
Why?
|
Emergencies | 1 | 2014 | 1209 | 0.070 |
Why?
|
Recovery of Function | 1 | 2017 | 2971 | 0.070 |
Why?
|
Kidney Function Tests | 1 | 2009 | 677 | 0.070 |
Why?
|
Drug Utilization | 2 | 2011 | 1187 | 0.070 |
Why?
|
Algorithms | 3 | 2023 | 13959 | 0.070 |
Why?
|
Carcinoma, Renal Cell | 1 | 2002 | 3217 | 0.070 |
Why?
|
Kidney Calices | 1 | 2006 | 26 | 0.070 |
Why?
|
Cultural Characteristics | 1 | 2007 | 251 | 0.070 |
Why?
|
Urinary Calculi | 1 | 2006 | 91 | 0.070 |
Why?
|
Socioeconomic Factors | 3 | 2016 | 7817 | 0.060 |
Why?
|
Pregnancy Complications | 1 | 2019 | 2942 | 0.060 |
Why?
|
Psychometrics | 1 | 2015 | 3050 | 0.060 |
Why?
|
Middle Aged | 14 | 2016 | 219560 | 0.060 |
Why?
|
Bone Nails | 1 | 2006 | 218 | 0.060 |
Why?
|
Sensitivity and Specificity | 5 | 2020 | 14641 | 0.060 |
Why?
|
Faculty, Medical | 1 | 2013 | 1192 | 0.060 |
Why?
|
Intraoperative Complications | 1 | 2011 | 1184 | 0.060 |
Why?
|
Urination Disorders | 1 | 2005 | 240 | 0.060 |
Why?
|
Prognosis | 4 | 2017 | 29558 | 0.060 |
Why?
|
Glutathione S-Transferase pi | 2 | 2001 | 100 | 0.060 |
Why?
|
Tissue Expansion | 1 | 2005 | 160 | 0.060 |
Why?
|
Diet | 1 | 2022 | 8003 | 0.060 |
Why?
|
Genetic Markers | 2 | 2017 | 2608 | 0.060 |
Why?
|
Potassium Chloride | 1 | 2004 | 230 | 0.060 |
Why?
|
Diagnosis-Related Groups | 1 | 2005 | 449 | 0.060 |
Why?
|
Leadership | 1 | 2013 | 1371 | 0.060 |
Why?
|
Sex Distribution | 1 | 2008 | 2283 | 0.060 |
Why?
|
Chi-Square Distribution | 2 | 2010 | 3425 | 0.050 |
Why?
|
Guideline Adherence | 2 | 2011 | 2215 | 0.050 |
Why?
|
Anticonvulsants | 1 | 2013 | 1881 | 0.050 |
Why?
|
Abbreviations as Topic | 1 | 2002 | 8 | 0.050 |
Why?
|
Dermis | 1 | 2004 | 202 | 0.050 |
Why?
|
Thulium | 1 | 2022 | 21 | 0.050 |
Why?
|
Holmium | 1 | 2022 | 29 | 0.050 |
Why?
|
Radiology | 1 | 2016 | 2102 | 0.050 |
Why?
|
Analgesics, Opioid | 1 | 2019 | 3765 | 0.050 |
Why?
|
Calcium Oxalate | 1 | 2022 | 75 | 0.050 |
Why?
|
Multifactorial Inheritance | 1 | 2010 | 1365 | 0.050 |
Why?
|
Tissue and Organ Harvesting | 1 | 2005 | 373 | 0.050 |
Why?
|
Muscle Spasticity | 1 | 2023 | 156 | 0.050 |
Why?
|
Mutation | 2 | 2017 | 29915 | 0.050 |
Why?
|
Thigh | 1 | 2003 | 240 | 0.050 |
Why?
|
Osteomyelitis | 1 | 2006 | 407 | 0.050 |
Why?
|
Wound Healing | 1 | 2013 | 2783 | 0.050 |
Why?
|
Pelvic Floor | 1 | 2003 | 138 | 0.050 |
Why?
|
Sodium Chloride | 1 | 2004 | 588 | 0.050 |
Why?
|
Prostatic Diseases | 1 | 2001 | 57 | 0.050 |
Why?
|
Bone Transplantation | 1 | 2006 | 922 | 0.050 |
Why?
|
Biotransformation | 1 | 2001 | 166 | 0.050 |
Why?
|
Ileum | 1 | 2003 | 555 | 0.050 |
Why?
|
Forecasting | 1 | 2010 | 2920 | 0.050 |
Why?
|
Public Health | 1 | 2014 | 2658 | 0.050 |
Why?
|
Gait | 1 | 2006 | 812 | 0.050 |
Why?
|
Prostheses and Implants | 1 | 2007 | 1270 | 0.040 |
Why?
|
Body Image | 1 | 2005 | 637 | 0.040 |
Why?
|
Animals | 4 | 2023 | 167777 | 0.040 |
Why?
|
Pressure | 1 | 2003 | 1155 | 0.040 |
Why?
|
Mutation, Missense | 2 | 2022 | 2564 | 0.040 |
Why?
|
Patient Compliance | 1 | 2010 | 2685 | 0.040 |
Why?
|
Health Care Costs | 1 | 2013 | 3245 | 0.040 |
Why?
|
General Surgery | 1 | 2011 | 1677 | 0.040 |
Why?
|
Patient Transfer | 1 | 2005 | 777 | 0.040 |
Why?
|
Absenteeism | 1 | 2020 | 249 | 0.040 |
Why?
|
Muscle Contraction | 1 | 2003 | 1196 | 0.040 |
Why?
|
Chronic Disease | 1 | 2013 | 9266 | 0.040 |
Why?
|
Electric Stimulation | 1 | 2003 | 1732 | 0.040 |
Why?
|
Precancerous Conditions | 2 | 2001 | 977 | 0.040 |
Why?
|
Biopsy, Needle | 1 | 2003 | 1630 | 0.040 |
Why?
|
Neoplasm Staging | 2 | 2003 | 11152 | 0.040 |
Why?
|
Videoconferencing | 1 | 2020 | 203 | 0.040 |
Why?
|
Cytosol | 1 | 2001 | 886 | 0.040 |
Why?
|
Universities | 1 | 2022 | 993 | 0.040 |
Why?
|
Linear Models | 1 | 2007 | 5861 | 0.040 |
Why?
|
Models, Animal | 1 | 2023 | 2112 | 0.040 |
Why?
|
Heredity | 1 | 2017 | 148 | 0.040 |
Why?
|
Fibrosis | 1 | 2004 | 2038 | 0.040 |
Why?
|
Attitude to Health | 1 | 2005 | 2025 | 0.030 |
Why?
|
Physical Examination | 1 | 2002 | 1244 | 0.030 |
Why?
|
Radiographic Image Enhancement | 1 | 2021 | 875 | 0.030 |
Why?
|
Aged | 8 | 2003 | 168217 | 0.030 |
Why?
|
Surgery, Computer-Assisted | 1 | 2003 | 1008 | 0.030 |
Why?
|
Bicarbonates | 1 | 2016 | 292 | 0.030 |
Why?
|
Sulfates | 1 | 2016 | 379 | 0.030 |
Why?
|
Lower Extremity | 1 | 2023 | 1188 | 0.030 |
Why?
|
Logistic Models | 2 | 2010 | 13276 | 0.030 |
Why?
|
Cost Savings | 1 | 2020 | 918 | 0.030 |
Why?
|
Emergency Service, Hospital | 1 | 2014 | 7810 | 0.030 |
Why?
|
Travel | 1 | 2020 | 785 | 0.030 |
Why?
|
Oxidative Stress | 2 | 2001 | 3100 | 0.030 |
Why?
|
Injury Severity Score | 1 | 2016 | 1033 | 0.030 |
Why?
|
Obesity, Morbid | 1 | 2004 | 1277 | 0.030 |
Why?
|
Glycosylation | 1 | 2016 | 1095 | 0.030 |
Why?
|
Tumor Cells, Cultured | 1 | 2001 | 6127 | 0.030 |
Why?
|
Immunoblotting | 1 | 2016 | 1647 | 0.030 |
Why?
|
Transfection | 1 | 2001 | 5779 | 0.030 |
Why?
|
Embolization, Therapeutic | 1 | 2002 | 1407 | 0.030 |
Why?
|
Phantoms, Imaging | 1 | 2021 | 2509 | 0.030 |
Why?
|
Neoplasm Metastasis | 1 | 2003 | 4901 | 0.030 |
Why?
|
Protein Folding | 1 | 2016 | 867 | 0.030 |
Why?
|
Sequence Homology, Amino Acid | 1 | 2016 | 2753 | 0.020 |
Why?
|
Fluorescent Antibody Technique | 1 | 2016 | 2470 | 0.020 |
Why?
|
Journal Impact Factor | 1 | 2013 | 153 | 0.020 |
Why?
|
Pain, Postoperative | 1 | 2002 | 1721 | 0.020 |
Why?
|
Prostatic Intraepithelial Neoplasia | 2 | 2001 | 81 | 0.020 |
Why?
|
Ambulatory Care | 1 | 2022 | 2768 | 0.020 |
Why?
|
Lipoproteins, LDL | 1 | 1994 | 640 | 0.020 |
Why?
|
Drug Resistance, Microbial | 1 | 2014 | 856 | 0.020 |
Why?
|
Age of Onset | 1 | 2017 | 3298 | 0.020 |
Why?
|
Protein Transport | 1 | 2016 | 1963 | 0.020 |
Why?
|
Qualitative Research | 1 | 2020 | 2976 | 0.020 |
Why?
|
Health Services Accessibility | 1 | 2007 | 5403 | 0.020 |
Why?
|
Pedigree | 1 | 2017 | 4578 | 0.020 |
Why?
|
Perioperative Period | 1 | 2011 | 262 | 0.020 |
Why?
|
Reference Values | 1 | 2016 | 4919 | 0.020 |
Why?
|
Magnetic Resonance Imaging | 1 | 2016 | 36285 | 0.020 |
Why?
|
Medical Staff, Hospital | 1 | 2013 | 600 | 0.020 |
Why?
|
Postoperative Hemorrhage | 1 | 2012 | 413 | 0.020 |
Why?
|
Gene Expression Regulation, Neoplastic | 2 | 2001 | 8506 | 0.020 |
Why?
|
Protein Conformation | 1 | 2016 | 3966 | 0.020 |
Why?
|
Genetic Association Studies | 1 | 2017 | 2717 | 0.020 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 1 | 1994 | 3801 | 0.020 |
Why?
|
DNA | 1 | 2001 | 7199 | 0.020 |
Why?
|
Aged, 80 and over | 2 | 2002 | 58681 | 0.020 |
Why?
|
DNA Mutational Analysis | 1 | 2014 | 4106 | 0.020 |
Why?
|
Autoantibodies | 1 | 1994 | 2118 | 0.020 |
Why?
|
Unnecessary Procedures | 1 | 2008 | 411 | 0.020 |
Why?
|
Program Evaluation | 1 | 2013 | 2490 | 0.010 |
Why?
|
Amino Acid Sequence | 1 | 2016 | 13447 | 0.010 |
Why?
|
High-Throughput Nucleotide Sequencing | 1 | 2016 | 3615 | 0.010 |
Why?
|
Kaplan-Meier Estimate | 1 | 2014 | 6493 | 0.010 |
Why?
|
Immunoglobulin G | 1 | 1994 | 4540 | 0.010 |
Why?
|
Lasers | 1 | 2006 | 952 | 0.010 |
Why?
|
Prostatitis | 1 | 2001 | 102 | 0.010 |
Why?
|
Catheterization | 1 | 2006 | 1426 | 0.010 |
Why?
|
Drug Administration Schedule | 1 | 2008 | 4839 | 0.010 |
Why?
|
Anticarcinogenic Agents | 1 | 2001 | 249 | 0.010 |
Why?
|
Phenotype | 1 | 2017 | 16534 | 0.010 |
Why?
|
Referral and Consultation | 1 | 2011 | 3586 | 0.010 |
Why?
|
Quality of Health Care | 1 | 2013 | 4317 | 0.010 |
Why?
|
Biomedical Research | 1 | 2013 | 3417 | 0.010 |
Why?
|
CpG Islands | 1 | 2001 | 1221 | 0.010 |
Why?
|
Gene Expression Regulation, Enzymologic | 1 | 2001 | 1171 | 0.010 |
Why?
|
Genetic Predisposition to Disease | 1 | 2017 | 17768 | 0.010 |
Why?
|
Thiobarbituric Acid Reactive Substances | 1 | 1994 | 45 | 0.010 |
Why?
|
Buffers | 1 | 1994 | 144 | 0.010 |
Why?
|
Malondialdehyde | 1 | 1994 | 111 | 0.010 |
Why?
|
Antioxidants | 1 | 2001 | 1662 | 0.010 |
Why?
|
Lipid Peroxidation | 1 | 1994 | 271 | 0.010 |
Why?
|
Research Design | 1 | 2008 | 6154 | 0.010 |
Why?
|
Cell Transformation, Neoplastic | 1 | 2001 | 2825 | 0.010 |
Why?
|
DNA Damage | 1 | 2001 | 2439 | 0.010 |
Why?
|
Serum Albumin | 1 | 1994 | 673 | 0.010 |
Why?
|
Education, Medical, Graduate | 1 | 2002 | 2359 | 0.010 |
Why?
|
Antigens | 1 | 1994 | 1445 | 0.000 |
Why?
|
Oxidation-Reduction | 1 | 1994 | 2222 | 0.000 |
Why?
|
Immunohistochemistry | 1 | 2001 | 11070 | 0.000 |
Why?
|
DNA Methylation | 1 | 2001 | 4373 | 0.000 |
Why?
|
Lupus Erythematosus, Systemic | 1 | 1994 | 2159 | 0.000 |
Why?
|